Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Imatinib (QTI571) in Pulmonary Arterial Hypertension
A 24-week Randomized Placebo-controlled, Double-blind Multi-center Clinical Trial Evaluating the Efficacy and Safety of Oral QTI571 as an add-on Therapy in the Treatment of Severe Pulmonary Arterial Hypertension: Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (IMPRES)
Status: Enrolling
Updated:  2/16/2016
Novartis Investigator Site
mi
from
Milwaukee, WI
Imatinib (QTI571) in Pulmonary Arterial Hypertension
A 24-week Randomized Placebo-controlled, Double-blind Multi-center Clinical Trial Evaluating the Efficacy and Safety of Oral QTI571 as an add-on Therapy in the Treatment of Severe Pulmonary Arterial Hypertension: Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (IMPRES)
Status: Enrolling
Updated: 2/16/2016
Novartis Investigator Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Imatinib (QTI571) in Pulmonary Arterial Hypertension
A 24-week Randomized Placebo-controlled, Double-blind Multi-center Clinical Trial Evaluating the Efficacy and Safety of Oral QTI571 as an add-on Therapy in the Treatment of Severe Pulmonary Arterial Hypertension: Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (IMPRES)
Status: Enrolling
Updated:  2/16/2016
Novartis investigative site
mi
from
Innsbruck,
Imatinib (QTI571) in Pulmonary Arterial Hypertension
A 24-week Randomized Placebo-controlled, Double-blind Multi-center Clinical Trial Evaluating the Efficacy and Safety of Oral QTI571 as an add-on Therapy in the Treatment of Severe Pulmonary Arterial Hypertension: Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (IMPRES)
Status: Enrolling
Updated: 2/16/2016
Novartis investigative site
mi
from
Innsbruck,
Click here to add this to my saved trials
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated:  2/17/2016
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated: 2/17/2016
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Click here to add this to my saved trials
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated:  2/17/2016
Philadelphia VA Medical Center, Philadelphia, PA
mi
from
Philadelphia, PA
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated: 2/17/2016
Philadelphia VA Medical Center, Philadelphia, PA
mi
from
Philadelphia, PA
Click here to add this to my saved trials
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated:  2/17/2016
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated: 2/17/2016
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated:  2/17/2016
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
mi
from
Bedford, MA
DVDs About Blood Pressure
Using Stories to Address Disparities in Hypertension
Status: Enrolling
Updated: 2/17/2016
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
mi
from
Bedford, MA
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Mobile, AL
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Deerfield Beach, FL
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Atlanta, GA
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Valparaiso, IN
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Valparaiso, IN
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Charlotte, NC
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Harrisburg, NC
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Harrisburg, NC
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Raleigh, NC
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Salisbury, NC
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Greenville, SC
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Mt. Pleasant, SC
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Dallas, TX
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
mi
from
Kenosha, WA
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
mi
from
Kenosha, WA
Click here to add this to my saved trials
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated:  2/17/2016
mi
from
Bahia Blanca,
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Status: Enrolling
Updated: 2/17/2016
mi
from
Bahia Blanca,
Click here to add this to my saved trials
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated:  2/18/2016
GSK Investigational Site
mi
from
Boston, MA
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 2/18/2016
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated:  2/18/2016
GSK Investigational Site
mi
from
Dallas, TX
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 2/18/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated:  2/18/2016
GSK Investigational Site
mi
from
Rosario,
A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Status: Enrolling
Updated: 2/18/2016
GSK Investigational Site
mi
from
Rosario,
Click here to add this to my saved trials
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
Status: Enrolling
Updated:  2/19/2016
St. John's Mercy Cardiovascular Research
mi
from
St. Louis, MO
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
Status: Enrolling
Updated: 2/19/2016
St. John's Mercy Cardiovascular Research
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure
A Structured Program for Hypertension Control in Community Clinics: A Randomized Trial
Status: Enrolling
Updated:  2/23/2016
Brentwood Unity Health Care Center
mi
from
Washington,
A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure
A Structured Program for Hypertension Control in Community Clinics: A Randomized Trial
Status: Enrolling
Updated: 2/23/2016
Brentwood Unity Health Care Center
mi
from
Washington,
Click here to add this to my saved trials
A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure
A Structured Program for Hypertension Control in Community Clinics: A Randomized Trial
Status: Enrolling
Updated:  2/23/2016
Congress Heights Unity Health Care Center
mi
from
Washington,
A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure
A Structured Program for Hypertension Control in Community Clinics: A Randomized Trial
Status: Enrolling
Updated: 2/23/2016
Congress Heights Unity Health Care Center
mi
from
Washington,
Click here to add this to my saved trials
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
Status: Enrolling
Updated:  2/23/2016
University of Florida
mi
from
Gainesville, FL
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
Status: Enrolling
Updated: 2/23/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated:  2/25/2016
Cobb County Community Service Board
mi
from
Marietta, GA
The Health Outcomes Management and Evaluation (HOME) Study
Improving Primary Care of Patients With Mental Disorders
Status: Enrolling
Updated: 2/25/2016
Cobb County Community Service Board
mi
from
Marietta, GA
Click here to add this to my saved trials
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
Study to Estimate the Incidence and Prevalence and Treatment Patterns of Pediatric Pulmonary Hypertension in the US
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Boston, MA
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
Study to Estimate the Incidence and Prevalence and Treatment Patterns of Pediatric Pulmonary Hypertension in the US
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Faith-based Approaches in the Treatment of Hypertension (FAITH)
Faith-based Approaches in the Treatment of Hypertension (FAITH)
Status: Enrolling
Updated:  2/29/2016
NYU School of Medicine
mi
from
New York, NY
Faith-based Approaches in the Treatment of Hypertension (FAITH)
Faith-based Approaches in the Treatment of Hypertension (FAITH)
Status: Enrolling
Updated: 2/29/2016
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated:  3/10/2016
University of Colorado Eye Center
mi
from
Aurora, CO
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Status: Enrolling
Updated: 3/10/2016
University of Colorado Eye Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated:  3/15/2016
Mayo Clinic
mi
from
Jacksonville, FL
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated: 3/15/2016
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated:  3/15/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated: 3/15/2016
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Micro-Clinic Obesity and Metabolic Risk Prevention Program
Micro-Clinic Obesity and Metabolic Risk Prevention Program: A Randomized-Control Trial of a Social-Network Based Intervention
Status: Enrolling
Updated:  3/15/2016
Bell County Health Department
mi
from
Pineville, KY
Micro-Clinic Obesity and Metabolic Risk Prevention Program
Micro-Clinic Obesity and Metabolic Risk Prevention Program: A Randomized-Control Trial of a Social-Network Based Intervention
Status: Enrolling
Updated: 3/15/2016
Bell County Health Department
mi
from
Pineville, KY
Click here to add this to my saved trials
Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated:  3/15/2016
Richard Roudebush VA Medical Center, Indianapolis
mi
from
Indianapolis, IN
Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Richard Roudebush VA Medical Center, Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated:  3/15/2016
Richard Roudebush VA Medical Center
mi
from
Indianapolis, IN
Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Richard Roudebush VA Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
Pulmonary Hemodynamic Effects of Stored Red Blood Cell Transfusion in Post-Operative Cardiac Surgical Patients: Influence of Breathing Nitric Oxide. A Randomized Controlled Trial in the Cardiac-Intensive Care Unit.
Status: Enrolling
Updated:  3/16/2016
Massachusetts General Hospital
mi
from
Boston, MA
Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
Pulmonary Hemodynamic Effects of Stored Red Blood Cell Transfusion in Post-Operative Cardiac Surgical Patients: Influence of Breathing Nitric Oxide. A Randomized Controlled Trial in the Cardiac-Intensive Care Unit.
Status: Enrolling
Updated: 3/16/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Status: Enrolling
Updated:  3/17/2016
University of Utah
mi
from
Salt Lake City, UT
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Status: Enrolling
Updated: 3/17/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Status: Enrolling
Updated:  3/17/2016
VA Salt Lake City Health Care System
mi
from
Salt Lake City, UT
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
Status: Enrolling
Updated: 3/17/2016
VA Salt Lake City Health Care System
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
National Health and Nutrition Examination Survey 24-hour Urine Collection Feasibility Study, 2013
National Health and Nutrition Examination Survey 24-Hour Urine Collection Feasibility Study, 2013
Status: Enrolling
Updated:  3/24/2016
National Health and Nutrition Examination Survey
mi
from
Hyattsville, MD
National Health and Nutrition Examination Survey 24-hour Urine Collection Feasibility Study, 2013
National Health and Nutrition Examination Survey 24-Hour Urine Collection Feasibility Study, 2013
Status: Enrolling
Updated: 3/24/2016
National Health and Nutrition Examination Survey
mi
from
Hyattsville, MD
Click here to add this to my saved trials
To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension
A Two Part Study Including a Randomized, Double Blind, Placebo Controlled, Multiple Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LFF269 After b.i.d Dosing in Healthy Volunteers and an Open Label, Multiple Dose Pharmacokinetics Study in Hypertension Subjects
Status: Enrolling
Updated:  3/30/2016
Novartis Investigative Site
mi
from
Miami, FL
To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension
A Two Part Study Including a Randomized, Double Blind, Placebo Controlled, Multiple Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LFF269 After b.i.d Dosing in Healthy Volunteers and an Open Label, Multiple Dose Pharmacokinetics Study in Hypertension Subjects
Status: Enrolling
Updated: 3/30/2016
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Status: Enrolling
Updated:  3/31/2016
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Pilot Study of Home Blood Pressure Control Program (eBP Control)
Status: Enrolling
Updated: 3/31/2016
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Click here to add this to my saved trials